Gossamer Bio Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021	2020	2019	2018	2017	2016
Market Capitalization	167	206	205	865	734	1,032	-	-	-
Market Cap Growth	-	0.33%	-76.29%	17.78%	-28.87%	-	-	-	-
Enterprise Value	80	118	172	722	401	668	-229	6	-0
PE Ratio	-1.14	-1.14	-0.89	-3.70	-3.02	-5.72	-	-	-
PB Ratio	2.67	3.28	16.98	7.12	2.29	2.93	-	-	-
P/FCF Ratio	-1.29	-1.29	-1.09	-4.54	-4.13	-6.98	-	-	-
P/OCF Ratio	-1.29	-1.29	-1.10	-4.58	-4.16	-7.13	-	-	-
EV/EBITDA Ratio	-0.73	-0.73	-0.82	-3.45	-1.77	-3.81	1.56	-0.85	0.24
EV/EBIT Ratio	-0.71	-0.71	-0.80	-3.36	-1.74	-3.74	1.56	-0.85	0.24
EV/FCF Ratio	-0.74	-0.74	-0.92	-3.79	-2.26	-4.52	4.20	-1.00	-1.00
Debt / Equity Ratio	3.33	3.33	18.44	1.50	0.56	0.11	-	-0.88	-0.33
Debt / EBITDA Ratio	-1.29	-1.29	-1.06	-0.87	-0.80	-0.21	-	-0.89	-0.48
Debt / FCF Ratio	-1.31	-1.31	-1.19	-0.96	-1.01	-0.25	-	-1.05	2.00
Quick Ratio	5.74	5.74	5.19	8.16	13.28	10.88	11.22	0.25	0.42
Current Ratio	5.94	5.94	5.32	8.32	13.51	11.09	11.37	0.35	0.42
Interest Coverage	-12.31	-12.31	-15.53	-11.04	-18.21	-92.04	-12246.42	-	-
Return on Equity (ROE)	-944.80%	-944.80%	-1117.20%	-119.40%	-68.60%	-43.10%	231.60%	193.90%	-
Return on Assets (ROA)	-67.80%	-67.80%	-80.70%	-56.90%	-45.90%	-37.60%	-122.50%	-2681.60%	-
Return on Capital (ROIC)	-67.58%	-67.58%	-93.08%	-71.14%	-46.72%	-47.77%	124.09%	809.37%	100.00%
Earnings Yield	-107.42%	-87.42%	-111.88%	-27.06%	-33.15%	-17.47%	-	-	-
FCF Yield	-95.08%	-77.38%	-91.43%	-22.02%	-24.22%	-14.32%	-	-	-
Buyback Yield / Dilution	-80.46%	-80.46%	-13.00%	-9.24%	-25.16%	-741.53%	28.99%	-	-
Total Shareholder Return	-80.46%	-80.46%	-13.00%	-9.24%	-25.16%	-741.53%	28.99%	-	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).